skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Technetium-99m-exametazine: Pitfalls in preparation and quality control

Journal Article · · Journal of Nuclear Medicine Technology; (USA)
OSTI ID:6698509
 [1]
  1. Loyola Univ. of Medical Center, Maywood, IL (USA)

The Food and Drug Administration recently approved the drug exametazine (Cretec or hexamethylenepropylene-amineoxime) for use in preparation of a {sup 99m}Tc-chelate suitable for human use. This radiopharmaceutical is indicated for detection of altered regional cerebral perfusion in patients with stoke. Unlike the majority of radiopharmaceuticals containing stannous ion (Sn{sup 2+}), which can be prepared by addition of varying volumes and activities of ({sup 99m}Tc)pertechnetate, successful preparation of {sup 99m}Tc-exametazime requires careful control of both volume and activity. The necessity for careful control of the final chemical concentration and radioconcentration is based on the minimal amount of Sn{sup 2+} ion present.

OSTI ID:
6698509
Journal Information:
Journal of Nuclear Medicine Technology; (USA), Vol. 17:4; ISSN 0091-4916
Country of Publication:
United States
Language:
English

Similar Records

Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions
Journal Article · Mon Jun 01 00:00:00 EDT 1987 · J. Nucl. Med.; (United States) · OSTI ID:6698509

Radiation decomposition of technetium-99m radiopharmaceuticals. [Glucnates, pyrophosphates, and serum albumins]
Journal Article · Thu Feb 01 00:00:00 EST 1979 · J. Nucl. Med.; (United States) · OSTI ID:6698509

Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits
Journal Article · Sun Nov 01 00:00:00 EST 1981 · Am. J. Hosp. Pharm.; (United States) · OSTI ID:6698509